News

Articles

Pfizer’s proposed $2.26-billion acquisition of Trillium Therapeutics will add next-generation hematology-targeted immuno-therapeutics to its oncology pipeline.

Pfizer to Acquire Trillium Therapeutics in $2.26-Billion Deal

HHS Public Health and a team of medical experts recommend that COVID-19 vaccine booster shots will soon be necessary. 

HHS Public Health Makes Statement on COVID-19 Booster Shots

FDA approved the Pfizer-BioNTech COVID-19 vaccine, which will be marketed as Comirnaty.

FDA Approves First COVID-19 Vaccine from Pfizer-BioNTech

The agency has amended the emergency use authorizations for the Pfizer-BioNTech and Moderna vaccines to allow certain immunocompromised people to receive an additional dose of the vaccine.

FDA Authorizes Additional COVID-19 Vaccine Dose for Certain Individuals

Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with The Biovac Institute Ltd to manufacture the Pfizer-BioNTech COVID-19 vaccine for distribution within the African Union.

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

Eli Lilly and Company has announced its acquisition of biotech firm Protomer Technologies, giving it a protein-engineering platform for next-generation protein therapeutics.

Lilly Acquires Protomer Technologies in Potential $1-Billion Deal

USP adds services to support supply chain for safe medicines. 

USP Acquires Pharmatech Associates

Reports of myocarditis and pericarditis following Pfizer-BioNTech and Moderna vaccinations prompts warnings.

FDA Adds Warning to mRNA Vaccine Fact Sheets

GlaxoSmithKline will focus on vaccines and specialty medicines while spinning off consumer healthcare business.

GSK Announces Consumer Business Demerger

The US government will invest $3 billion from the American Rescue Plan into a COVID-19 antiviral development strategy.

Top News